185 results on '"Kane, J.M."'
Search Results
2. Impact of treatment with TV-46000, a long-acting subcutaneous antipsychotic (LASCA), at different stages of schizophrenia: a post hoc analysis
3. Long-term safety, tolerability, and effectiveness of TV-46000 —a long-acting subcutaneous antipsychotic (lasca)—in patients with schizophrenia: the phase 3 shine study
4. Contingency planning and risk mitigation strategies for a schizophrenia relapse prevention trial during the COVID-19 pandemic
5. Delphi panel on management, treatment goals and functional recovery with long-acting injectable antipsychotics in first episode and early phase schizophrenia
6. Clinical dilemmas in schizophrenia treatment and the potential place in therapy of long-acting antipsychotic agents
7. Dispelling myths and misconceptions surrounding the use of long-acting injectable antipsychotic agents for treatment of schizophrenia
8. P.0777 Treatment journey of patients with schizophrenia from diagnosis to the successful implementation of treatment with a long-acting injectable antipsychotic agent
9. P.0760 Prevalence of atypical antipsychotic use among patients with schizophrenia in the United States: an analysis of a commercial claims database
10. Seed banks in a degraded desert shrubland: Influence of soil surface condition and harvester ant activity on seed abundance
11. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy
12. HSD3 Real-World Outcomes and Practice Patterns for Long-Acting Injectable Vs. Oral Antipsychotic Agents Among Hospitalized Patients with Schizophrenia in the United States
13. P.320 Risk/benefit balance of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis
14. P.556 Long-acting injectable vs. oral antipsychotics for preventing rehospitalisation in schizophrenia: a meta-analysis of randomised, mirror-image, and cohort studies
15. 93 A standardized mouse model of hyperthermic intraperitoneal chemotherapy (HIPEC)
16. P.461 Behavioral economics to improve medication adherence in severe mental illness: A systematic review of current evidence
17. P.671 Efficacy and safety of lumateperone tosylate 42mg in the treatment of schizophrenia: A pooled analysis of phase 2 and 3 studies
18. C.07.04 Is there a sense of urgency to optimise relapse prevention and functioning in patients with schizophrenia?
19. Often claimed, rarely tested: individual drug response in antipsychotic drug trials
20. C.01.02 Individualisation of treatment in schizophrenia
21. Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group (vol 23, pg 3531, 2016)
22. Adjuvant Regional Nodal Radiation in Sentinel Lymph Node Positive Merkel Cell Carcinoma without Completion Lymph Node Dissection
23. Clozapine as an early-stage treatment
24. The concept of resilience: definition and measurement
25. Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group
26. The role of the cavus foot in peroneal tendon pathology
27. Efficacy of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator
28. Safety of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator
29. Inverse relationship between body mass index and mortality in older nursing-home residents: A collaborative meta-analysis of 19,538 elderly subjects
30. Mega-review of meta-analyses investigating the short-term efficacy of pharmacologic augmentation strategies of antipsychotics in patients with schizophrenia
31. S.15.01 - The concept of resilience: definition and measurement
32. P.3.d.072 Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies
33. P.3.d.067 Long-acting injectable vs oral antipsychotics for hospitalisation prevention in schizophrenia: a systematic review/meta-analysis of cohort studies
34. P.3.d.037 Effects of aripiprazole once-monthly in patients with schizophrenia switched from oral antipsychotics to aripiprazole once-monthly
35. P.3.d.034 Effects of aripiprazole once-monthly on functioning in patients with schizophrenia
36. P.3.d.046 Switching from oral antipsychotics to aripiprazole once-monthly in a naturalistic setting: hospitalisation rates from a mirror study
37. DYSGLYCEMIC SIGNALS IN CHILDREN AND ADOLESCENTS TREATED WITH ANTIPSYCHOTICS FOR THE FIRST TIME
38. P.3.f.007 - Safety of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator
39. P.3.f.006 - Efficacy of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator
40. Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia
41. P.3.d.027 Aripiprazole once-monthly for schizophrenia: a double-blind, randomised, non-inferiority study versus oral aripiprazole
42. C.04.01 Protecting patients from the long-term consequences of schizophrenia
43. P.3.c.018 A placebo-controlled study of efficacy/safety of aripiprazole intramuscular depot for long-term maintenance treatment of schizophrenia
44. P.3.c.033 Long-acting injectable vs. oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image and cohort studies
45. P.3.c.040 Ziprasidone and the QTc interval: a comprehensive review
46. FC13-10 - Frequency of prolonged qtc in children and adolescents hospitalized for psychiatric disorders: a nested case-control study
47. P.3.c.060 Differences in early responders/early non-responders to atypical antipsychotics on functional outcomes in schizophrenia
48. Comparative mortality associated with ziprasidone vs. olanzapine in real-world use: The ziprasidone observational study of cardiac outcomes (zodiac)
49. Cardiac risk factors and schizophrenia: An analysis of 18,094 patients enrolled in an international comparative trial of olanzapine and ziprasidone
50. Computerized neurocognitive assessment: Clinical trials and FMRI applications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.